Asthma and COPD are among the most challenging and complex conditions for healthcare providers and organizations to manage.

  • Many patients struggle to manage their disease and adhere to their prescribed medication regimen.
  • Clinicians frequently lack the tools to easily identify which patients need more attention.
  • And the direct costs of asthma and COPD in the U.S. are more than $100 billion annually.1

1. Helleman DE, et al. (2000) Chest, 118: 1278 - 1275. Barnett SB, et al. (2011) Journal of Allergy and Clinical Immunology, 127(1)

Want to use Propeller in your practice? Have questions?

Click here for help

Are you a patient interested in using our product? Contact [email protected].

Patient tools

  • Propeller sensors are compatible with more than 20 leading controller and rescue medications. They simply clip onto patients' existing inhalers and passively track medication use (See full list of medications).

  • The Propeller app uses robust analytics to help patients identify triggers, symptoms, trends and other personalized insights.


Clinician tools

  • Clinicians are alerted when a patient transitions to a poorly controlled status, enabling proactive care and outreach

  • Clinicians receive reports that include patients’ medication adherence, trigger and symptom trends, and ACT/CAT scores to prescribe or modify care

  • The clinician panel integrates with leading health information systems and EMRs


Analytics and data science

  • The entire Propeller solution is powered by robust analytics and data science

  • Patients better understand their condition and feel empowered to take control, while clinicians have new data to help patients improve health outcomes


Program rollout takes less than a month, and is proven to deliver better outcomes for asthma and COPD.

improvement in medication adherence1
reduction in rescue inhaler usage2
increase in symptom-free days3
reduction in asthma-related ED visits4

1. Van Sickle D, Humblet O, Barrett M, Henderson K, and Hogg C. 2016. Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence. European Respiratory Journal:48: PA1018.

2. Merchant, R. K., Inamdar, R., & Quade, R. C. (2016). Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial. The Journal of Allergy and Clinical Immunology: In Practice, 4(3), 455-463.

3. Barrett, M., Combs, V., Su, J. G., Henderson, K., Tuffli, M., & AIR Louisville Collaborative. (2018). AIR Louisville: Addressing Asthma With Technology, Crowdsourcing, Cross-Sector Collaboration, And Policy. Health Affairs, 37(4), 525-534.

4. Merchant, R., Tuffli, M., Barrett, M., Hogg, C., Van Sickle, D., & Stempel, D. (2017). Impact of A Digital Health Intervention On Asthma Healthcare Utilization.

FDA cleared.
Trusted by leading U.S. healthcare providers.

Partnerships with four of the leading health systems in the United States, and five leading national and regional health plans.

9 FDA clearances, CE Marking, ISO 13485 and HITRUST

Trusted by more than 530 doctors, respiratory therapists, care managers and nurses who make up the Propeller Provider Network


Want to learn how you can incorporate Propeller into your practice or organization?

Just fill out the form below and a member of the Propeller crew will review your request.


Are you a patient interested in using our product? Contact [email protected].